Q&A
iPC Healthcare Investment Sleeve Portfolio 1
INTRODUCTION:
iPC Healthcare Investment Portfolios have exclusive holdings of IN-LICENSED and/or DEVELOPMENT extremely complex generic drugs which we manage through the new drug applications (505 b2s or 505 b1s). The portfolio(s) are constructed with synergies between the underlying pharmaceuticals within portfolio.Â
Management Team with best-in class technically proven solutions
Proven Team:Â Leadership +100Â years, with deep respect in the scientific community through invited lectures, international patents, peer-reviewed publications, and a highly regarded book chapter on lung cancer.
Â
Proven Track-record:Â Successfully created a drug product portfolio of more than USD 10B. Lead and commercialized 100+ drug products with a cumulative value of USD +50B in US and other leading global markets
iPC Healthcare Investment Portfolio(s) value drivers of drugs within portfolios
